Meeting
2020 Gastrointestinal Cancers Symposium
Changing the landscape of germline testing in patients with pancreatic adenocarcinoma.
Authors
Aly Athens
Levine Cancer Institute-Atrium Health, Charlotte, NC
Aly Athens , Lisa Amacker-North , Kelly Warsinske , Kunal C. Kadakia , Edward S. Kim , Mohamed E. Salem , Sara Elrefai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 676)
Abstract #
676
Poster Bd #
J7
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.
First Author: Jose Luis Rodriguez Olivares
Poster
2024 ASCO Genitourinary Cancers Symposium
Prevalence of variant of unknown significance (VUS) in men with prostate cancer who serve as a benchmark for enhanced screening and for personalized therapy.
First Author: Vittorio Fasulo
Poster
2023 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller
Poster
2022 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller